Australia Markets close in 4 hrs 55 mins
  • ALL ORDS

    7,490.10
    -178.80 (-2.33%)
     
  • ASX 200

    7,175.80
    -166.60 (-2.27%)
     
  • AUD/USD

    0.7187
    -0.0041 (-0.5620%)
     
  • OIL

    0 (0)
     
  • GOLD

    1,836.10
    -6.50 (-0.35%)
     
  • BTC-AUD

    51,056.97
    +389.22 (+0.77%)
     
  • CMC Crypto 200

    839.82
    +29.21 (+3.60%)
     
  • AUD/EUR

    0.6333
    -0.0054 (-0.85%)
     
  • AUD/NZD

    1.0702
    +0.0008 (+0.07%)
     
  • NZX 50

    12,348.00
    -149.10 (-1.19%)
     
  • NASDAQ

    14,509.58
    +71.18 (+0.49%)
     
  • FTSE

    7,494.13
    -90.88 (-1.20%)
     
  • Dow Jones

    34,364.50
    +99.10 (+0.29%)
     
  • DAX

    15,603.88
    -308.42 (-1.94%)
     
  • Hang Seng

    24,965.55
    +13.25 (+0.05%)
     
  • NIKKEI 225

    27,522.26
    -250.64 (-0.90%)
     

Nephros Announces Third Quarter 2021 Financial Results Conference Call

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • NEPH

SOUTH ORANGE, NJ, Oct. 21, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc.(Nasdaq: NEPH), a leading water technology company providing filtration and pathogen detection solutions to the medical and commercial markets, today announced that it will file its third quarter financial results on Thursday, November 4, 2021 after market close and will host a conference call that same day at 4:30 PM ET.

Participants may dial into the call as follows:
Domestic access: 1-844-808-7106
International access: 1-412-317-5285

Upon joining, please ask to be joined into the Nephros conference call.

A replay of the call can be accessed until November 11, 2021 at 1-877-344-7529or 1-412-317-0088for international callers and entering replay access code: 10160005.

An audio archive of the call will be available shortly after the call on the Nephros investor relations page at https://investors.nephros.com/events/.

About Nephros
Nephros, Inc. is a company committed to improving the human relationship with water through leading, accessible technology. We provide innovative filtration and pathogen detection as part of an integrated approach to water safety that combines science, solutions, and support services. Nephros products serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency responses for water management. For more information about Nephros, please visit www.nephros.com.

Investor Relations Contacts:
Kirin Smith, President
PCG Advisory, Inc.
(646) 823-8656
ksmith@pcgadvisory.com
www.pcgadvisory.com

Andy Astor, President and CEO
Nephros, Inc.
(201) 345-0824
andy@nephros.com
www.nephros.com


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting